Brief: Rapt Therapeutics Q1 Net Income USD -30.521 Million
May 09 (Reuters) - Rapt Therapeutics Q1 basic EPS USD -0.79. * Q1 operating income USD -32.518 million * Q1 operating expenses USD 32.518 million
May 09 (Reuters) - Rapt Therapeutics Q1 basic EPS USD -0.79. * Q1 operating income USD -32.518 million * Q1 operating expenses USD 32.518 million